comparison of Fingolimode and Betaferon(high dose) in M.S treatment
Not Applicable
- Conditions
- M.S.Multiple Sclerosis
- Registration Number
- IRCT2015112025146N1
- Lead Sponsor
- Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
The most important one is MS patients who had treatment failure (relapsing rate more than one) under Betaferon ( low dose) ; patient acceptance; non immunosuppressive patient.
Exclusion criteria: noncooperative patient; death
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disability Status. Timepoint: befor intervention and 3.9.12.18 months after intervention. Method of measurement: Check list of E.D.S.S.;Relapse Numbers. Timepoint: 0,3,9,12,18 months after intervention. Method of measurement: History and observation.
- Secondary Outcome Measures
Name Time Method